Attached files

file filename
S-1 - S-1 - Day One Biopharmaceuticals, Inc.d155073ds1.htm
EX-21.1 - EX-21.1 - Day One Biopharmaceuticals, Inc.d155073dex211.htm
EX-10.8 - EX-10.8 - Day One Biopharmaceuticals, Inc.d155073dex108.htm
EX-10.7 - EX-10.7 - Day One Biopharmaceuticals, Inc.d155073dex107.htm
EX-10.6 - EX-10.6 - Day One Biopharmaceuticals, Inc.d155073dex106.htm
EX-10.5 - EX-10.5 - Day One Biopharmaceuticals, Inc.d155073dex105.htm
EX-10.4 - EX-10.4 - Day One Biopharmaceuticals, Inc.d155073dex104.htm
EX-10.3 - EX-10.3 - Day One Biopharmaceuticals, Inc.d155073dex103.htm
EX-10.2 - EX-10.2 - Day One Biopharmaceuticals, Inc.d155073dex102.htm
EX-10.1 - EX-10.1 - Day One Biopharmaceuticals, Inc.d155073dex101.htm
EX-4.2 - EX-4.2 - Day One Biopharmaceuticals, Inc.d155073dex42.htm
EX-3.5 - EX-3.5 - Day One Biopharmaceuticals, Inc.d155073dex35.htm
EX-3.4 - EX-3.4 - Day One Biopharmaceuticals, Inc.d155073dex34.htm
EX-3.3 - EX-3.3 - Day One Biopharmaceuticals, Inc.d155073dex33.htm
EX-3.2 - EX-3.2 - Day One Biopharmaceuticals, Inc.d155073dex32.htm
EX-3.1 - EX-3.1 - Day One Biopharmaceuticals, Inc.d155073dex31.htm
EX-2.1 - EX-2.1 - Day One Biopharmaceuticals, Inc.d155073dex21.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 19, 2021, in the Registration Statement (Form S-1) and related Prospectus of Day One Biopharmaceuticals Holding Company, LLC, for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Redwood City, California

May 4, 2021